What is the current stock price of Kadimastem Ltd (KMSTF)?

As of the latest market data, Kadimastem Ltd (KMSTF) is trading at $3.21. The stock has seen a loss of -3.02% today.

Does Kadimastem Ltd (KMSTF) pay a dividend?

Based on current data, Kadimastem Ltd does not have a confirmed active dividend policy.

What is the market cap of Kadimastem Ltd?

The current market capitalization of Kadimastem Ltd (KMSTF) is approximately unavailable.

KMSTF

Kadimastem Ltd·Healthcare

3.21

3.021%(−0.10)

Market Closed

Last Updated: — ET

52W L: $0.6452W H: $9.07

Company Profile

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was founded in 2008 and is based in Ness Ziona, Israel.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-02-01

Beta

0.57

Websitewww.kadimastem.com↗